Ketamine in the Treatment of Depression
The Antidepressant Action of Ketamine: Brain Chemistry
Sponsor: Columbia University
A PHASE2 clinical study on Major Depressive Disorder, this trial is completed. The trial is conducted by Columbia University and has accumulated 13 data snapshots since 2012. Longitudinal tracking of this trial contributes to a broader understanding of treatment development timelines.
Status Flow
Change History
13 versions recorded-
Sep 2024 — Present [monthly]
Completed PHASE2
-
Jul 2024 — Sep 2024 [monthly]
Completed PHASE2
-
Jan 2023 — Jul 2024 [monthly]
Completed PHASE2
-
Dec 2022 — Jan 2023 [monthly]
Completed PHASE2
-
Jan 2021 — Dec 2022 [monthly]
Completed PHASE2
▶ Show 8 earlier versions
-
Jan 2020 — Jan 2021 [monthly]
Completed PHASE2
Status: Active Not Recruiting → Completed
-
Sep 2019 — Jan 2020 [monthly]
Active Not Recruiting PHASE2
-
Aug 2019 — Sep 2019 [monthly]
Active Not Recruiting PHASE2
-
May 2019 — Aug 2019 [monthly]
Active Not Recruiting PHASE2
Status: Unknown Status → Active Not Recruiting
-
Jan 2019 — May 2019 [monthly]
Unknown Status PHASE2
Status: Active Not Recruiting → Unknown Status
-
Jun 2018 — Jan 2019 [monthly]
Active Not Recruiting PHASE2
-
Feb 2017 — Jun 2018 [monthly]
Active Not Recruiting PHASE2
-
Jan 2017 — Feb 2017 [monthly]
Active Not Recruiting PHASE2
First recorded
Feb 2012
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- Columbia University
- National Institute of Mental Health (NIMH)
For direct contact, visit the study record on ClinicalTrials.gov .